Evidence map›Paper›PMID 14978266›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

Molecular chaperones function as steroid receptor nuclear mobility factors.

Cem Elbi, Dawn A Walker, Guillermo Romero, William P Sullivan, David O Toft, Gordon L Hager, Donald B DeFranco

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 143 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Modulation of androgen receptor by FOXA1 and FOXO1 factors in prostate cancer.International journal of biological sciences · 2014
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Cem ElbiLaboratory of Receptor Biology and Gene Expression, Building 41, Room B602, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055, USA.
Dawn A Walker
Guillermo Romero
William P Sullivan
David O Toft
Gordon L Hager
Donald B DeFranco
National Cancer Institute · USUniversity of Pittsburgh · US

Funding

In vivo Imaging Analysis of SteroidNuclear Receptor FunctionZIABC010308 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HAGER, GORDON L · 2009 to 2025
$8.4M
In vivo Imaging of Steroid/Nuclear Receptor FunctionZ01BC010308 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HAGER, GORDON · 1999 to 2008
$735k
6 · The paper itself

Abstract

Live cell imaging has revealed the rapid mobility of steroid hormone receptors within nuclei and their dynamic exchange at transcriptionally active target sites. Although a number of other proteins have been shown to be highly mobile within nuclei, the identity of soluble factors responsible for orchestrating nuclear trafficking remains unknown. We have developed a previously undescribed in situ subnuclear trafficking assay that generates transcriptionally active nuclei, which are depleted of soluble factors required for the nuclear mobility of glucocorticoid (GR) and progesterone receptors (PR). Using this system and a fluorescence recovery after photobleaching technique, we demonstrate that nuclear mobility of GR recovered on incubation with reticulocyte lysate was inhibited by geldanamycin, a drug that blocks the chaperone activity of heat-shock protein 90. Direct proof of molecular chaperone involvement in steroid receptor subnuclear trafficking was provided by the ATP-dependent recovery of nuclear mobility of GR and PR on incubation with various combinations of purified chaperone and/or cochaperone proteins. Additionally, for both receptors, the inclusion of hormone during the recovery period leads to a retardation of nuclear mobility. Thus, our results provide a description of soluble nuclear mobility factors and furthermore demonstrate a previously unrecognized role for molecular chaperones in the regulation of steroid receptor function within the nucleus.

Indexed as

Active Transport, Cell NucleusAdenosine TriphosphateAnimalsCell Line, TumorCell NucleusGreen Fluorescent ProteinsHumansKineticsLuminescent ProteinsMammary Neoplasms, ExperimentalMiceMolecular ChaperonesRatsReceptors, GlucocorticoidReceptors, ProgesteroneReceptors, SteroidAdenosine TriphosphateGreen Fluorescent ProteinsLuminescent ProteinsMolecular ChaperonesReceptors, GlucocorticoidReceptors, ProgesteroneReceptors, SteroidRecombinant Fusion Proteins

Identifiers

PMID14978266
PMCPMC365713
OpenAlexW2010820473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.